Ir al contenido

Relación con inversores

Tecnología médica sueca para la nariz: en el trabajo, en el día a día y para su olfato.

Último informe

Nosa Plugs AB Interim Report for the Third Quarter 2026

6 de noviembre de 2026

Próximo evento

Calendario financiero: upcoming dates are published in the interim reports.

Calendario financiero

Entrevistas en vídeo

Todas las presentaciones

Financial targets

Short-term financial targets – 2025–2026

Growth target
Net sales of at least SEK 50 million in 2026.
Profitability target
Positive EBITDA from Q4 2025 and an EBITDA margin of at least 15 per cent in 2026.

Medium-term financial targets – 2027–2028

Growth target
Average organic net sales growth of at least 25 per cent per year.
Profitability target
EBITDA margin of at least 18 per cent.
Capital structure
Net debt in relation to EBITDA shall not exceed 3 times.
Dividend policy
Surplus shall be distributed to shareholders when free cash flow exceeds available investments in profitable growth. Dividends require that the capital structure target is met.

Going forward, NOSA will also continue to evaluate acquisition opportunities within ear, nose and throat (ENT).

Equity research

Análisis, comentarios y entrevistas sobre Nosa Plugs de Analyst Group.

Ver más

Fuente: Analyst Group. Actualizado continuamente.

Suscribirse a comunicados

Recibe comunicados e informes por correo a través de MFN.

Suscribirse

Contacto IR

Adrian Liljefors

VD

ir@nosaplugs.com

Company details

Company
Nosa Plugs AB (publ)
Address
Surbrunnsgatan 42, 113 48 Stockholm, Sverige
Phone
+46 (0)771 112 000